Astrazeneca Share News (AZN)
AZN Share
AZN Share
AZN Share
AZN Share
AZN
AZN Share
AZN Level 2
AZN Live
AZN Broker
AZN Directors
AZN Financial
AZN
AZN Short
AZN
Last checked at -
* Soriot took home 15.45 mln stg - High Pay Centre report* Experian CEO Cassin in second place with 10.3 mln stg* Median FTSE 100 CEO pay down 17% in pandemic-hit yearBy Simon JessopLONDON, Aug 19 (Reuters) - Pascal Soriot, the chief executive of CO...
Read moreBy Ludwig BurgerAug 19 (Reuters) - A British public health study has found that protection from either of the two most commonly used COVID-19 vaccines against the now prevalent Delta variant of the coronavirus weakens within three months.It also f...
Read moreBy Joice AlvesLONDON, Aug 17 (Reuters) - London's FTSE 100 index will lose its second largest company by market capitalisation if shareholders back plans by global resource giant BHP Group to end its dual listing structure and make Australia its ...
Read moreCAIRO, Aug 17 (Reuters) - Britain donated 299,700 doses of Oxford-AstraZeneca's COVID-19 vaccine to Egypt, the World Health Organization (WHO) said on Tuesday.The shots were shipped via the global COVAX initiative, with the support of UNICEF and W...
Read more(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* UK employment closer to pre-pandemic levels* BHP Group jumps on strong results* PLUS500 gains on robust revenue forecasts* FTSE 100 up 0.3%...
Read more
Ireland set to halt further orders of AstraZeneca and J&J vaccines
Read moreBELGRADE, Aug 15 (Reuters) - The Serbian health authorities authorised a third dose of COVID-19 vaccines for people with compromised immune systems, health workers and anyone vaccinated at least six months ago, country's labour minister said on S...
Read more
(Sharecast News) - Ministers must be prepared to block a takeover of Meggitt if any bidder tries to buy it without giving binding commitments on investment and jobs, the FTSE 250 aerospace and defence manufacturer's chairman warned this weekend. Sir Nigel Rudd said that while "clearly, price is important", any new owner would need to give Meggitt and the government undertakings, including to keep the company's headquarters in Coventry and maintain R&D spending. - Sunday Times
Read more(Updates with FDA approval of boosters for immunocompromised in para 4)By Michael ErmanNEW YORK, Aug 13 (Reuters) - Drugmakers Pfizer Inc, BioNTech and Moderna Inc are expected to reap billions of dollars from COVID-19 booster shots in a market th...
Read moreBy Michael ErmanNEW YORK, Aug 13 (Reuters) - Drugmakers Pfizer Inc, BioNTech and Moderna Inc are expected to reap billions of dollars from COVID-19 booster shots in a market that could rival the $6 billion in annual sales for flu vaccines for year...
Read more(Recasts with Pfizer vaccine deal)By Sangmi ChaSEOUL, Aug 13 (Reuters) - South Korea on Friday signed a deal to buy 30 million doses of Pfizer's COVID-19 vaccine for 2022, and the government urged people to cut holiday travel amid a worsening four...
Read moreAug 12 (Reuters) - The U.S. Food and Drug Administration is working with vaccine makers Pfizer Inc and Moderna Inc to allow certain vulnerable people to receive a third booster shot of their COVID-19 vaccines to improve their immune response, the...
Read moreIN BRIEF: Silence Therapeutics revenue up, new targets with AstraZeneca
Read moreBy Chantha LachPHNOM PENH, Aug 12 (Reuters) - Cambodia started offering coronavirus vaccine booster shots on Thursday in a renewed public health drive after managing to inoculate more than half of its population.One of Asia's poorest countries, Ca...
Read more(Sharecast News) - Analysts at JP Morgan resumed their coverage of AstraZeneca at 'overweight', telling clients they saw a "re-rating opportunity".
Read more
Last checked at